Novo A/S »

Avalyn Pharma shares owned by Novo A/S

Quarter-by-quarter ownership of Avalyn Pharma shares owned by Novo A/S from 13F filings

Historical chart of Novo A/S investment in Avalyn Pharma

Tip: Access up to 7 years of quarterly data

All positions including Avalyn Pharma held by Novo A/S consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalyn Pharma by Novo A/S

Quarter filed Position value Share count Share price at filing
2026-06-30 $128M 3.9M 32.92

More positions owned by Novo A/S

Edgewise Therapeutics (EWTX)
Asml Holding N V N Y Registry Shs (ASML)
Hemab Therapeutics Hldgs Com Shs
Brookfield Corp Cl A Ltd Vt Sh (BN)
Maplight Therapeutics (MPLT)
Mirum Pharmaceuticals (MIRM)
Avalyn Pharmaceuticals Com Shs
salesforce (CRM)
Arrivent Biopharma (AVBP)
Enliven Therapeutics (ELVN)
Crinetics Pharmaceuticals In (CRNX)
Pharvaris N V (PHVS)
Floor & Decor Hldgs Cl A (FND)
Vaxcyte (PCVX)
4d Molecular Therapeutics In (FDMT)

View all positions for Novo A/S

Top funds holding Avalyn Pharma

Novo A/S
Sr One Capital Management
Perceptive Advisors
NVP Associates
Pivotal bioVenture Partners Investment Advisor
Citadel Advisors
Braidwell
Vanguard Capital Management
Soleus Capital Management
Infinitum Asset Management
Baker Bros. Advisors
Goldman Sachs Group
Federated Investors
ADAR1 Capital Management
Vanguard Portfolio Management

View all funds holding Avalyn Pharma